Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Merck & Co
(NY:
MRK
)
83.01
-1.41 (-1.67%)
Official Closing Price
Updated: 7:00 PM EST, Feb 14, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
26,779,119
Open
84.42
Bid (Size)
83.00 (1)
Ask (Size)
83.09 (3)
Prev. Close
84.42
Today's Range
82.09 - 84.78
52wk Range
82.09 - 134.63
Shares Outstanding
2,531,374,696
Dividend Yield
3.71%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
MRK Investors Have Opportunity to Lead Merck & Co., Inc. Securities Fraud Lawsuit with the Schall Law Firm
February 15, 2025
From
The Schall Law Firm
Via
Business Wire
MarketBeat Week in Review – 02/10 - 02/14
February 15, 2025
Despite many negative headlines, stocks are trading near all-time highs; next week will be a shortened trading week, with most of the monthly economic data in
Via
MarketBeat
Topics
Credit Cards
Economy
Government
Exposures
Interest Rates
Political
Tariff
Performance
YTD
-16.30%
-16.30%
1 Month
-15.23%
-15.23%
3 Month
-14.03%
-14.03%
6 Month
-27.45%
-27.45%
1 Year
-34.83%
-34.83%
More News
Read More
10 Health Care Stocks With Whale Alerts In Today's Session
February 14, 2025
Via
Benzinga
Decoding Merck & Co's Options Activity: What's the Big Picture?
February 13, 2025
Via
Benzinga
Recent Filing Shows That Rep. Josh Gottheimer Sold Over $54K Worth of Merck & Co Stock
February 11, 2025
Via
Benzinga
Market Whales and Their Recent Bets on MRK Options
February 06, 2025
Via
Benzinga
In a market where value is scarce, NYSE:MRK offers a refreshing opportunity with its solid fundamentals.
February 14, 2025
Via
Chartmill
MRK INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Merck & Co., Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
February 14, 2025
From
Robbins Geller Rudman & Dowd LLP
Via
Business Wire
Rosen Law Firm Urges Merck & Co., Inc. (NYSE: MRK) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
February 13, 2025
From
The Rosen Law Firm, P.A.
Via
Business Wire
Top 3 Health Care Stocks You'll Regret Missing This Month
February 06, 2025
Via
Benzinga
Why Merck Stock Is Plummeting Today
February 04, 2025
Via
The Motley Fool
Robert F. Kennedy, Vaccine Skeptic, Confirmed As Trump's Secretary Of Health: Health Care Stocks To Watch
February 13, 2025
Via
Benzinga
Topics
Government
Exposures
Political
3 Blue-Chip Dividend Stocks Trading at Multiyear Lows
February 13, 2025
Via
The Motley Fool
Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever.
February 13, 2025
Via
The Motley Fool
Rosen Law Firm Encourages Merck & Co. Inc. Investors to Inquire About Securities Class Action Investigation – MRK
February 12, 2025
From
The Rosen Law Firm, P.A.
Via
Business Wire
Neuphoria Stock Jumps On Triggering $15M Milestone Payment From Merck For Alzheimer's Study: Retail Interest Explodes
February 12, 2025
Via
Stocktwits
Gilead Sciences Beats Q4 EPS Forecast
February 11, 2025
Via
The Motley Fool
Merck Stock Heads For 5th Day Of Losses As TD Cowen Downgrades On Gardasil Woes, But Retail Holds Strong
February 10, 2025
Via
Stocktwits
Merck: 4 No-Brainer Reasons to Buy This Dip
February 10, 2025
Via
MarketBeat
Better High-Yield Dividend Stock: Pfizer vs. Merck
February 10, 2025
Via
The Motley Fool
Merck Announces Phase 3 waveLINE-010 Trial Initiation Evaluating Zilovertamab Vedotin, an Investigational Antibody-Drug Conjugate, for the Treatment of Patients With Previously Untreated Diffuse Large B-Cell Lymphoma
February 06, 2025
From
Merck & Co., Inc.
Via
Business Wire
Analysts Defend Merck Amid Investor Concerns Over Weak Guidance
February 05, 2025
Via
Benzinga
Uncover the latest developments among S&P500 stocks in today's session.
February 04, 2025
Via
Chartmill
Merck (MRK) Q4 2024 Earnings Call Transcript
February 04, 2025
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Looking for the most active stocks in the S&P500 index on Tuesday?
February 04, 2025
Via
Chartmill
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.